11 research outputs found

    Report of the Regional Co-ordination Meeting for the North Sea and Eastern Arctic (RCM NS&EA) 2013

    Get PDF
    Report of the Regional Co-ordination Meeting for the North Sea and Eastern Arctic (RCM NS&EA) 2013 final report European Fisheries Control Agency (EFCA) Vigo, Spain 09/09/2013-13/09/2013The Regional Coordination Meeting for the North Sea & Eastern Arctic (RCM NS&EA) was held in September 2013 in Vigo (Spain). The main task of the RCM’s is to coordinate the National Programmes (NP), which propose the national data collection to be carried out by the Member States (MS) under the EU Data Collection Framework (DCF). It was envisaged that, from 2104 onwards, data collection by the MS would be carried out under a new framework (DC-MAP). However, the legislation for this framework is not ready yet. Therefore the Commission has decided to extend the present DCF for the time being and the most recent NPs have been adopted for 2014. Since these NP have been adopted without any changes, there is no need for major coordinatio

    Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness

    Get PDF
    This article describes the preclinical profile of fexinidazole, a new drug candidate with the potential to become a novel, oral, safe and effective short-course treatment for curing both stage 1 and 2 human African trypanosomiasis and replace the old and highly problematic treatment modalities available today. Fexinidazole is orally available and rapidly metabolized in two metabolites having equivalent biological activity to the parent and contributing significantly to the in vivo efficacy in animal models of both stage 1 and 2 HAT. Animal toxicology studies indicate that fexinidazole has an excellent safety profile, with no particular issues identified. Fexinidazole is a 5-nitroimidazole and, whilst it is Ames-positive, it is devoid of any genetic toxicity in mammalian cells and therefore does not pose a genotoxic risk for use in man. Fexinidazole, which was rediscovered through a process of compound mining, is the first new drug candidate for stage 2 HAT having entered clinical trials in thirty years, and has the potential to revolutionize therapy of this fatal disease at a cost that is acceptable in the endemic regions

    Elucidating the migrations of European seabass from the southern north sea using mark-recapture data, acoustic telemetry and data storage tags

    No full text
    The movement ecology of European seabass, Dicentrarchus labrax, remains poorly understood, especially in the northern ranges of its distribution. To investigate migration patterns of seabass from the southern North Sea, we combined data from different projects from four countries using various tagging techniques. This resulted in 146 recaptures (out of 5598 externally marked seabass), 138 detected animals (out of 162 seabass fitted with an acoustic transmitter) and 76 archived depth and temperature series (out of 323 seabass with an archival tag). Using geolocation modelling, we distinguished different migration strategies, whereby individual fish migrated to the eastern English Channel (15.1%), the western English Channel (28.3%), the Celtic Sea and the norther part of the Bay of Biscay (17.0%), or stayed in the North Sea (39.6%). A high number of seabass exhibited fidelity to the North Sea (90.5% of recaptures, 55.3% for acoustic transmitters and 44.7% of archival tags). Although seabass are generally considered to migrate southwards in winter, a large number of individuals (n = 62) were observed in the southern North Sea, where spawning might potentially occur in a particular deep location along the coast of Norfolk in the UK. Our results highlight the need to consider fine-scaled population structuring in fisheries assessment, and indicate that current seasonal fisheries closures are not aligned with the ecology of seabass in the North Sea
    corecore